Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight […]
Apr 11, 2025
Can we support fill finish?
Yes. We offer GMP-compliant fill finish services for viral vectors, allogeneic cell therapies, and other small-batch biologics. Our fill finish suite includes a Grade C cleanroom and Grade A isolator, suitable for clinical-stage vial or bag filling. We provide this as a standalone service or integrated within a broader manufacturing programme, with full GMP oversight and documentation.
Latest News
Developing iPSC Therapies: Why Your CMC Strategy Needs to Start Early
Jul 15, 2025
eXmoor Pharma Strengthens Leadership Team with New CEO Appointment
Jul 8, 2025
Industry News
eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
Jun 17, 2025
Industry News
Let’s Accelerate Your Therapy Together
Whether you're in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.